Poster - 20 October 2024 Receptor occupancy assay development challenges for rare targets of bispecific drugs
Poster - 28 July 2024 Analytical performance of the plasma β-Amyloid 1-40 and 1-42 assays on the Fujirebio® LUMIPULSE® G1200 to support Alzheimer’s Disease clinical trials
Poster - 17 November 2024 A 29-day two-dose and 3-day one-dose research and development study of intrathecal injection or epidural infusion in rats Read Moreabout A 29-day two-dose and 3-day one-dose research and development study of intrathecal injection or epidural infusion in rats
Poster - 17 November 2024 Comparison of intratracheal and inhaled AAV pulmonary deposition in two species Read Moreabout Comparison of intratracheal and inhaled AAV pulmonary deposition in two species
Poster - 17 November 2024 Inhaled delivery of a selective immune modulator to minipigs produces favorable toxicity profile Read Moreabout Inhaled delivery of a selective immune modulator to minipigs produces favorable toxicity profile
Poster - 17 November 2024 Mouse versus rabbit: Time course of corneal ocular toxicity of an antibody drug conjugate (ADC) with a maytansinoid payload Read Moreabout Mouse versus rabbit: Time course of corneal ocular toxicity of an antibody drug conjugate (ADC) with a maytansinoid payload
Poster - 17 November 2024 Retrospective analysis of nonclinical regulatory strategy for 13 approved oncology antibody-drug conjugates Read Moreabout Retrospective analysis of nonclinical regulatory strategy for 13 approved oncology antibody-drug conjugates
Webinar - 18 December 2024 Operationalizing Innovative Biomarkers to Support Evolving Therapeutic and Diagnostic Landscape for Neurodegenerative Diseases
Video - 25 April 2024 From Lab to Life: Unraveling the mysteries of nonclinical ADME and human AME (Insights for optimizing your hAME)
Info Sheet - 23 July 2024 Antibody drug-conjugates (ADCs): Analytical considerations for QC release, stability testing, characterization and comparability Read Moreabout Antibody drug-conjugates (ADCs): Analytical considerations for QC release, stability testing, characterization and comparability
Info Sheet - 23 July 2024 Labcorp Bioanalytical Services Antibody Drug-Conjugate (ADC) Services Read Moreabout Labcorp Bioanalytical Services Antibody Drug-Conjugate (ADC) Services
Article - 14 May 2024 Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese) Read Moreabout Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)
Info Sheet - 2 May 2024 Labcorp Biopharma Laboratory Services: Antibody-drug conjugate (ADC) capabilities Read Moreabout Labcorp Biopharma Laboratory Services: Antibody-drug conjugate (ADC) capabilities
Article - 8 April 2024 Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials Read Moreabout Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials
Article - 8 April 2024 Navigating complexities in ADC development with specialized global laboratory support and scientific expertise Read Moreabout Navigating complexities in ADC development with specialized global laboratory support and scientific expertise
Article - 7 December 2023 OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial Read Moreabout OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial
Article - 6 December 2023 Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay Read Moreabout Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay
Article - 28 September 2023 Cell therapy for treatment of cancer Read Moreabout Cell therapy for treatment of cancer